RBC Comments on Gilead Sciences (GILD) Harvoni Week 1 NRx
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Gilead Sciences's (GILD) Harvoni RX 445 in Week One
October 24, 2014 9:09 AM EDTGilead Sciences (NASDAQ: GILD) Harvoni scripts were 445 in week one, according to theStreet's Adam Feuerstein, citing IMS.
$GILD Harvoni Rx 445 in first week. Sovaldi first week Rx was 151.
Adam Feuerstein (@adamfeuerstein) October 24, 2014
